Has Henry Trattler received payments from drug or device companies?

Yes. Drug and device makers reported $8,338 in general payments to Henry Trattler across 251 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Henry Trattler did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Henry Trattler come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Henry Trattler

Ophthalmology · Miami, FLNPI 1184649170

Payments from drug & device makers

$8,338in general payments, 2019–2025

Across 251 payments — averaging $33.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bausch & Lomb Americas Inc.$874
Alcon$756
AbbVie$735
Sun Pharmaceutical Industries Inc.$642
Novartis$543
Mallinckrodt Hospital Products Inc.$483
plus $4K from 35 others

What the payments were for

Food & beverage$8,23099%
Education$1081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bausch & Lomb Americas Inc.	30	$874
Alcon	28	$756
AbbVie(2 entities)	19	$735
Sun Pharmaceutical Industries Inc.	11	$642
Novartis	27	$543
Mallinckrodt Hospital Products Inc.	26	$483
Kala Pharmaceuticals, Inc.	8	$375
Amgen(2 entities)	9	$373
Aerie Pharmaceuticals, Inc.	6	$327
Bausch & Lomb, A Division Of Bausch Health US, LLC	7	$241
Mallinckrodt Enterprises LLC	2	$230
Biotissue Holdings Inc.	10	$230
Johnson & Johnson Surgical Vision, Inc.	5	$218
Tarsus Pharmaceuticals, Inc.	3	$213
NEW World Medical,inc.	3	$201
Apellis Pharmaceuticals, Inc.	7	$184
Dompe US, Inc.	2	$172
Rayner Intraocular Lenses Limited	6	$168
Oyster Point Pharma, Inc.	8	$164
Beaver-visitec International, Inc.	1	$158
Sight Sciences, Inc.	2	$130
Regeneron Healthcare Solutions, Inc.	3	$103
ANI Pharmaceuticals, Inc.	3	$89
Carl Zeiss Meditec USA, Inc.	1	$80
Ocular Therapeutix, Inc.	1	$65
Astellas Pharma US Inc	2	$65
Merz Pharmaceuticals, LLC	2	$62
Carl Zeiss Meditec, Inc.	3	$58
Lensar, Inc.	2	$51
Thea Pharma Inc.	2	$46
Genentech USA, Inc.	2	$45
Coherus Oncology, Inc.	1	$44
Alimera Sciences, Inc.	1	$36
Immunocore Limited	1	$30
Harrow Eye, LLC	1	$28
Halozyme Inc	1	$26
Rxsight Inc	1	$25
Akorn, Inc.	1	$19
Omeros Corporation	1	$19
Eyevance Pharmaceuticals LLC	1	$19
Shire North American Group Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,338 in reported general payments places this provider in the 75th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LinzessLinaclotide	12	$6,237

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieLinzess	$735	$6,23712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,405 ophthalmology providers in Florida.

Other ophthalmology in Miami

Guillermo AmescuaMiami$962K
Felipe MedeirosMiami$935K
Jennifer LohMiami$606K
Jaclyn KovachMiami$590K
William TrattlerMiami$580K
Wilfredo LaraMiami$526K
Jayanth SridharMiami$525K
Kendall DonaldsonMiami$351K
David EichenbaumSt Petersburg$34.4M
Robert RadenDelray Beach$7.8M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →